CalRx represents a groundbreaking solution for addressing drug affordability. Originally announced in January 2019 in Governor Newsom’s first Executive Order and later signed into law in the California Affordable Drug Manufacturing Act of 2020 (Pan, SB 852, Chapter 207, Statutes of 2020), CalRx empowers the State of California to develop, produce, and distribute generic drugs and sell them at low cost. The State will target prescription drugs where the pharmaceutical market has failed to lower drug costs, even when a generic or biosimilar medication is available.
The Pharmaceutical Data Specialist applies research methodologies and data analysis to support the development, implementation, and evaluation of CalRx programmatic operations and strategies, including those to ensure equitable access. The incumbent independently performs more complex data research and analysis in response to ad-hoc research and reporting requests and synthesizes findings in written memos, reports, and presentations. This role keeps abreast of pharmaceutical industry data trends, health care policies, and rapidly changing developments within the pharmaceutical sector, and provides recommendations to executive leadership for project direction.
The incumbent will develop policy and procedural recommendations that have significant impact on the CalRx program, affecting program development and implementation, evaluation of potential vendors and partnerships, and access to affordable and critical prescription drugs throughout the state. This role requires creative and analytical thinking, excellent qualitative and quantitative research skills, and a strong ability to communicate research findings in written and presented materials.
All employees shall possess the general qualifications, as described in California Code of Regulations Title 2, Section 172, which include, but are not limited to integrity, honesty, dependability, thoroughness, accuracy, good judgment, initiative, resourcefulness, and the ability to work cooperatively with others.